Luba, R., Madera, G., Schusterman, R., Kolodziej, A., Hodgson, I., & Comer, S. D. (2024). Evaluating the Abuse Potential of Lenabasum, a Selective CB2 Cannabinoid Receptor Agonist. Journal of Pharmacology and Experimental Therapeutics, JPET-AR-2024-002129. https://doi.org/10.1124/jpet.124.002129

Nunes, E. V., Comer, S. D., Lofwall, M. R., Walsh, S. L., Peterson, S., Tiberg, F., Hjelmstrom, P., & Budilovsky-Kelley, N. R. (2024). Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use. JAMA Network Open, 7(6), e2417377. https://doi.org/10.1001/jamanetworkopen.2024.17377

Mannes, Z. L., Hasin, D. S., Martins, S. S., Gonçalves, P. D., Livne, O., de Oliveira, L. G., de Andrade, A. G., McReynolds, L. S., McDuff, D., Hainline, B., & Castaldelli-Maia, J. M. (2022). Do varsity college athletes have a greater likelihood of risky alcohol and cannabis use than non-athletes? Results from a National Survey in Brazil. Brazilian Journal of Psychiatry, 44(3), 289–297. https://doi.org/10.1590/1516-4446-2021-2236